Patent · US Active

Blockade of voltage dependent sodium channels

US7790761B2 · kind B2 · utility

7Cited by

5References

14Claims

0Family size

Assignee

University College London · GB

Inventors

Giti Garthwaite · London, GB
David Selwood · London, GB
Marcel Robert Kling · Melbourne, AU
Grant Wishart · London, GB

Key dates

Filing date	Dec 21, 2005
Grant date	Sep 7, 2010
Priority date	—
Expiry date	Jul 7, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula I and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.